title: Color Doppler sonography in the study of chronic ischemic nephropathy.
abstract: In western countries, the risk of cardiovascular disease has increased considerably in recent decades. This trend has been paralleled by an increase in cases of atherosclerotic renal disease, which is related to the improved prognosis of cardiovascular diseases, aging, and the increasing mean age of the general population. It is reasonable to expect that in the near future, there will be a sharp increase in the number of elderly patients with atherosclerotic vascular disease in chronic dialysis programs. The result will be a dramatic rise in the social and economic costs of dialysis that could constitute a true clinical emergency. In this epidemiologic scenario, one of the most important targets of 21st century nephrology will be the early diagnosis of chronic ischemic nephropathy and the development of new and more effective strategies for its treatment.Color Doppler (CD) ultrasonography has displayed high sensitivity, specificity, and positive and negative predictive values in the diagnosis of this disease in selected population, making it an ideal tool for use in screening programs. Eligibility for screening should be based on clinical criteria. For the most part, it will be aimed at adults (especially those who are elderly) with atherosclerotic vascular disease involving multiple districts and chronic kidney disease (CKD), stage 2-3, in the absence of a documented history of renal disease. In these patients, hypertension may be a secondary manifestation or a symptom of the ischemic nephropathy itself. The objectives of sonographic screening should be (1) to identify subjects in the population at risk who are affected by stenosis of the main renal artery (RAS); (2) to identify and characterize patients without RAS who have chronic ischemic nephropathy caused by nephroangiosclerosis and/or atheroembolic disease. The former group will require second-level diagnostic studies or angioplasty with stenting; the latter can be managed conservatively. The most important CD parameters in the workup of suspected RAS are those that are direct signs, i.e., increases in peak systolic velocity (PSV) and diastolic velocity (DV), spectral broadening, and an altered renal:aortic ratio (RAR). Their assessment requires full-length sampling of the renal artery and is associated with greater practical/technical difficulties. Measurement in triplicate of the PSV in the ostial, medial, and hilar segments of both arteries and bilateral measurement of parenchymal resistance indices are usually sufficient to detect the presence of stenosis and refer the patient for second-level studies. Important parameters for estimating the severity of a stenosis include the renal:aortic ratio (>3.5), disappearance of the early systolic peak in segmental vessels, lateralization of the resistance index (ΔRI > 0.05), and the evaluation of the acceleration index (AI) and acceleration time (AT). Second-level imaging studies (CT angiography, MR angiography) are still indispensable for precise definition of the location and extension of the stenosis and the therapeutic approach during digital subtraction angiography (DSA). In the absence of direct or indirect signs of RAS, increases in the intraparenchymal resistance indices (RI > 0.75-0.80; PI > 1.50) associated with systemic atherosclerotic disease are indicative of microcirculatory damage related to nephroangiosclerosis or atheroembolic disease.
authors: S. Anna School of Advanced Studies, Nephrology and Dialysis Unit, Department of Internal Medicine, University of Pisa, Italy.
authors: M
authors: M
authors: Meola
authors: I
authors: I
authors: Petrucci
keywords: Chronic ischemic nephropathy; Nephroangiosclerosis; Renal artery stenosis; Renal color Doppler; Renovascular disease
references: AJR Am J Roentgenol. 1995 Jan;164(1):31-41
references: 7998566
references: Radiology. 1999 Oct;213(1):258-64
references: 10540669
references: Radiographics. 1995 Jul;15(4):833-54; discussion 854-65
references: 7569132
references: Hypertension. 2002 Feb;39(2 Pt 2):699-703
references: 11882634
references: Ultrasound Med Biol. 1986 Dec;12(12):945-52
references: 2950645
references: Hypertension. 1996 Nov;28(5):785-90
references: 8901824
references: J Vasc Surg. 1991 Nov;14(5):658-67
references: 1942375
references: Radiology. 1997 Oct;205(1):121-7
references: 9314973
references: Am J Hypertens. 1996 Nov;9(11):1055-61
references: 8931829
references: N Engl J Med. 1966 May 26;274(21):1171-3
references: 5934954
references: Ultraschall Med. 2007 Feb;28(1):45-51
references: 17304412
references: Kidney Int. 1995 Jul;48(1):171-6
references: 7564074
references: Annu Rev Med. 2001;52:421-42
references: 11160787
references: J Vasc Interv Radiol. 2002 Nov;13(11):1069-83
references: 12427805
references: J Am Coll Cardiol. 2001 Mar 15;37(4):1135-40
references: 11263620
references: N Engl J Med. 2001 Feb 8;344(6):410-7
references: 11172177
references: Ann Intern Med. 1992 Nov 15;117(10):845-53
references: 1416561
references: Ultrasound Med Biol. 1997;23(6):889-97
references: 9300993
references: J Comput Assist Tomogr. 1999 Nov;23 Suppl 1:S101-10
references: 10608405
references: Mayo Clin Proc. 2000 May;75(5):435-6
references: 10807069
references: Radiology. 1996 Apr;199(1):165-9
references: 8633141
references: Radiology. 1997 Apr;203(1):71-5
references: 9122418
references: J Vasc Surg. 1986 Nov;4(5):450-6
references: 3534324
references: Clin Nephrol. 2000 May;53(5):333-43
references: 11305806
references: Blood Purif. 1996;14(4):305-14
references: 8873956
references: Kidney Int. 1988 Nov;34(5):729-43
references: 3059028
references: Am J Kidney Dis. 1998 Jan;31(1):28-34
references: 9428448
references: J Vasc Surg. 2002 Sep;36(3):443-51
references: 12218965
references: J Biomech. 1976;9(7):439-48
references: 939765
references: Hypertension. 1993 Apr;21(4):391-7
references: 8458640
references: AJR Am J Roentgenol. 1990 Jun;154(6):1223-7
references: 2110732
references: Nephrol Dial Transplant. 1996 Aug;11(8):1607-12
references: 8856220
references: J Hypertens. 1999 Feb;17(2):151-83
references: 10067786
references: J Am Soc Nephrol. 2004 Jan;15(1):134-41
references: 14694165
references: Surgery. 1963 Jul;54:250-9
references: 13934073
references: AJR Am J Roentgenol. 2007 Mar;188(3):798-811
references: 17312071
references: N Engl J Med. 2001 Feb 8;344(6):431-42
references: 11172181
references: Arch Intern Med. 1997 Nov 24;157(21):2413-46
references: 9385294
references: Radiology. 1992 Aug;184(2):487-92
references: 1620853
references: Radiology. 1997 Oct;205(1):109-13
references: 9314971
references: Eur J Nucl Med. 1993 Jul;20(7):617-23
references: 8370384
references: Surg Radiol Anat. 2005 Dec;27(5):395-403
references: 16177834
references: Ultrasound Med Biol. 2001 Jul;27(7):937-44
references: 11476928
references: Curr Treat Options Cardiovasc Med. 2002 Jun;4(3):255-265
references: 12003724
references: Am J Med. 1994 Jan;96(1):10-4
references: 8304356
references: Biorheology. 1979;16(3):231-48
references: 508933
references: J Am Soc Nephrol. 2004 Aug;15(8):1974-82
references: 15284283
references: J Hum Hypertens. 1999 Sep;13(9):595-603
references: 10482969